ALBBY (Alibaba Health Information Technology) Altman Z2-Score: 7.18 (As of Jun. 30, 2026) — 20% Above Median


ALBBY Alibaba Health Information Technology Ltd ALBBY
73 GF Score
Price $8.46
GF Value $14.18
Valuation Significantly Undervalued
! 2 Warning Signs
View Full Analysis

What is Alibaba Health Information Technology Altman Z2-Score?

Alibaba Health Information Technology ALBBY +6.82% 73 Altman Z2-Score is 7.18 as of Jun. 30, 2026, which is 20% above its 10-year median of 5.99. GuruFocus rates ALBBY with a GF Score™ of 73/100 and a GF Value™ of $14.18 (Significantly Undervalued). The stock has 2 warning signs investors should review. Among 675 Healthcare Providers & Services companies, Alibaba Health Information Technology ranks better than 84.15% on this metric.

Altman Z2-Score, also known as Z"-Score, is used to predict the likelihood that a non-manufacturing company (excluding property/financial company) will face bankruptcy within a two-year period.

Good Sign:

Alibaba Health Information Technology has a Altman Z2-Score of 7.18, indicating it is in Safe Zones. This implies the Altman Z2-Score is strong.

The zones of discrimination were as such:

When Altman Z2-Score <= 1.1, it is in Distress Zones.
When Altman Z2-Score >= 2.6, it is in Safe Zones.
When Altman Z2-Score is between 1.1 and 2.6, it is in Grey Zones.

The historical rank and industry rank for Alibaba Health Information Technology's Altman Z2-Score or its related term are showing as below:

ALBBY' s Altman Z2-Score Range Over the Past 10 Years
Min: 0.94   Med: 5.99   Max: 8.31
Current: 7.18

During the past 13 years, Alibaba Health Information Technology's highest Altman Z2-Score was 8.31. The lowest was 0.94. And the median was 5.99.


Alibaba Health Information Technology  (OTCPK:ALBBY) Altman Z2-Score Explanation

The original Z-Score model was based on publicly traded manufacturing companies while the Z2-Score, also known as Z"-score can be used for any type of company excluding property/financial companies. Both Z-Score and Z2-Score describes the financial health of a company, and its likelihood of financial distress.

X1: The Working Capital/Total Assets (WC/TA) ratio is a measure of the net liquid assets of the firm relative to the total capitalization. Working capital is defined as the difference between current assets and current liabilities. Ordinarily, a firm experiencing consistent operating losses will have shrinking current assets in relation to total assets. Altman found this one proved to be the most valuable liquidity ratio comparing with the current ratio and the quick ratio. This is however the least significant of the five factors.

X2: Retained Earnings/Total Assets: the RE/TA ratio measures the leverage of a firm. Retained earnings is the account which reports the total amount of reinvested earnings and/or losses of a firm over its entire life. Those firms with high RE, relative to TA, have financed their assets through retention of profits and have not utilized as much debt.

X3, Earnings Before Interest and Taxes/Total Assets (EBIT/TA): This ratio is a measure of the true productivity of the firm's assets, independent of any tax or leverage factors. Since a firm's ultimate existence is based on the earning power of its assets, this ratio appears to be particularly appropriate for studies dealing with corporate failure. This ratio continually outperforms other profitability measures, including cash flow.

X4_2, Net Worth (Total Stockholders Equity - Preferred Stock)/Total Liabilities (NW/TL): it compares a company’s stock net worth with its total liabilities and can be used to assess the extent of its reliance on debt.

Read more about Altman Z2-Score, the original research on Z-Score and the additional research on Z2-Score.


Be Aware

Altman Z2-Score does not apply to financial companies.


Alibaba Health Information Technology Altman Z2-Score Related Terms


Alibaba Health Information Technology Altman Z2-Score Historical Data

* Premium members only.

The historical data trend for Alibaba Health Information Technology's Altman Z2-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Alibaba Health Information Technology Altman Z2-Score Chart

Alibaba Health Information Technology Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Altman Z2-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only 5.56 5.89 6.09 6.55 7.18

Alibaba Health Information Technology Semi-Annual Data
Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25 Mar26
Altman Z2-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 6.09 0.00 6.55 0.00 7.18

Alibaba Health Information Technology Altman Z2-Score Competitor Comparison

For the Pharmaceutical Retailers subindustry, Alibaba Health Information Technology's Altman Z2-Score, along with its competitors' market caps and Altman Z2-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Alibaba Health Information Technology Altman Z2-Score vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Alibaba Health Information Technology's Altman Z2-Score distribution charts can be found below:

* The bar in red indicates where Alibaba Health Information Technology's Altman Z2-Score falls into.


ALBBY
73GF Score
Alibaba Health Information Technology Ltd ALBBY
Altman Z2-Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Alibaba Health Information Technology Altman Z2-Score Calculation

Altman Z-Score model is an accurate forecaster of failure up to two years prior to distress. It can be considered the assessment of the distress of industrial corporations.

Z2-Score, also known as Z"-Score is the Z-Score for non-manufacturing companies excluding property/financial companies.

Alibaba Health Information Technology's Altman Z2-Score for today is calculated with this formula:

Z=6.56*X1+3.26*X2+6.72*X3+1.05*X4_2
=6.56*0.4473+3.26*0+6.72*0.0985+1.05*3.4098
=7.18

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency. GuruFocus does not calculate Altman Z2-Score when X4_2 value is 0.

Trailing Twelve Months (TTM) ended in Mar. 2026:
Total Assets was $3,351 Mil.
Total Current Assets was $2,238 Mil.
Total Current Liabilities was $739 Mil.
Retained Earnings was $0 Mil.
Pre-Tax Income was $330 Mil.
Interest Expense was $-0 Mil.
Total Liabilities was $760 Mil.

* Note that for stock reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data.

X1=Working Capital/Total Assets
=(Total Current Assets - Total Current Liabilities)/Total Assets
=(2237.675 - 739.002)/3350.663
=0.4473

X2=Retained Earnings/Total Assets
=0/3350.663
=0

X3=Earnings Before Interest and Taxes/Total Assets
=(Pre-Tax Income - Interest Expense)/Total Assets
=(329.975 - -0.203)/3350.663
=0.0985

X4_2=Net Worth/Total Liabilities
=(Total Stockholders Equity - Preferred Stock)/Total Liabilities
=(2590.706 - 0)/759.789
=3.4098

The zones of discrimination were as such:

Distress Zones - 1.1 < Grey Zones < 2.6 - Safe Zones

Alibaba Health Information Technology has a Altman Z2-Score of 7.18 indicating it is in Safe Zones.

Frequently Asked Questions Learn more about Altman Z2-Score →
What does a Altman Z2-Score of 7.18 mean?
Alibaba Health Information Technology (ALBBY) has a Altman Z2-Score of 7.18 as of Jun. 30, 2026. Z2-Score is the Z-Score for non-manufacturing companies excluding property/financial companies, which measures a company's bankruptcy risk. View historical data on Alibaba Health Information Technology and its competitors. This is 20% above median its historical median of 5.99. Over the past decade, Alibaba Health Information Technology's Altman Z2-Score has ranged from 0.94 to 8.31. According to the industry distribution chart, Alibaba Health Information Technology ranks #107 out of 675 companies in the Healthcare Providers & Services industry, placing it in the top 15.9%.
Is Alibaba Health Information Technology's Altman Z2-Score too high?
Alibaba Health Information Technology's current Altman Z2-Score of 7.18 is 20% above median its 10-year median of 5.99. Over the past 10 years, this metric has ranged from a low of 0.94 to a high of 8.31. The Healthcare Providers & Services industry median Altman Z2-Score is 2.18. Alibaba Health Information Technology's value of 7.18 is 229.4% above this industry median. Based on the distribution chart, Alibaba Health Information Technology ranks #107 out of 675 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Alibaba Health Information Technology has a GF Score™ of 73/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Alibaba Health Information Technology's Altman Z2-Score compare to competitors?
According to the Healthcare Providers & Services industry distribution chart, Alibaba Health Information Technology ranks #107 out of 675 companies for Altman Z2-Score. This places Alibaba Health Information Technology in the top 16% of its industry — outperforming the majority of peers. The industry median Altman Z2-Score is 2.18. Alibaba Health Information Technology's value of 7.18 is 229.4% above this benchmark. Historically, Alibaba Health Information Technology's own Altman Z2-Score has ranged from 0.94 to 8.31 over the past decade. While the company's 10-year median is 5.99 vs. the industry median of 2.18, Alibaba Health Information Technology has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Altman Z2-Score for a Healthcare Providers & Services company?
The median Altman Z2-Score among Healthcare Providers & Services companies is 2.18, based on 675 companies in the industry. Companies in the top quartile (top 25%) have a Altman Z2-Score significantly above this median, while those in the bottom quartile fall well below. However, Altman Z2-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Alibaba Health Information Technology's current Altman Z2-Score of 7.18 is 229.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Altman Z2-Score mean?
A high Altman Z2-Score can signal that a stock is expensive relative to its fundamentals. Z2-Score is the Z-Score for non-manufacturing companies excluding property/financial companies, which measures a company's bankruptcy risk. View historical data on Alibaba Health Information Technology and its competitors. For the Healthcare Providers & Services industry, the median Altman Z2-Score is 2.18 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Alibaba Health Information Technology's current Altman Z2-Score is 7.18, which is 20% above median its own 10-year median of 5.99. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Alibaba Health Information Technology stock overvalued right now?
Based on GuruFocus' analysis, Alibaba Health Information Technology (ALBBY) is currently considered Significantly Undervalued. The stock's GF Value™ is $14.18, compared to a current price of $8.46 — trading 40.3% below its estimated fair value. The current Altman Z2-Score is 7.18, which is 20% above median its 10-year median of 5.99 and 229.4% above the Healthcare Providers & Services industry median of 2.18. Alibaba Health Information Technology's overall GF Score™ is 73/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Altman Z2-Score calculated?
Altman Z2-Score is calculated from a company's financial statements. For Alibaba Health Information Technology (ALBBY), the current Altman Z2-Score is 7.18 as of Jun. 30, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Alibaba Health Information Technology (ALBBY) Overvalued in 2026?

Based on GuruFocus' analysis, Alibaba Health Information Technology stock appears to be undervalued. The current stock price of $8.46 is trading 40.3% below its estimated GF Value™ of $14.18. GuruFocus considers Alibaba Health Information Technology to be Significantly Undervalued.

Key valuation signals for ALBBY:

  • Altman Z2-Score: 7.18 (20% above median its 10-year median of 5.99)
  • GF Value™: $14.18 vs. price of $8.46 (40.3% below fair value)
  • GF Score™: 73/100 with 2 warning signs
  • Industry Position: 229.4% above the Healthcare Providers & Services median (#107 of 675)

No single metric tells the full story. See the ALBBY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Alibaba Health Information Technology Business Description

Address Wangjing East Park, 30th Floor, Greenland Center, Building 9, Zone 4, Chaoyang District, Beijing, CHN
Alibaba Health is of one of China's leading e-commerce platform specializing in healthcare-related products, including prescription drugs, OTC drugs, traditional Chinese medicine, health foods, and so on. The company operates both a third-party B2C service, or 3P, and its own direct-to-consumer business, or 1P, with its own inventory, which can both be accessed by Alibaba's Tmall app and Alipay. The company also provides online consultation services in a separate app although its e-commerce businesses remain its core competency in the long-term. E-commerce accounted for 93% of revenue in fiscal year 2022. We estimate that AliHealth holds about 45% of market share in the industry in terms of GMV. AliHealth is 63.74% owned by its parent company, Alibaba Group.
73GF Score

Get the complete analysis for ALBBY

Altman Z2-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$8.46
Price
$14.18
GF Value